XML 170 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated statement of changes in equity - USD ($)
$ in Millions
Total
Issued Capital And Share Premium
[1]
Other equity instruments
[2]
Retained earnings
Available- for-sale fair value reserve
[6]
Cash flow hedging reserve
[6]
Foreign exchange reserve
[6]
Merger reserve
[6],[7]
Total shareholders’ equity
Noncontrolling interests
HSBC Holdings
HSBC Holdings
Called up share capital
HSBC Holdings
Share premium
HSBC Holdings
Other equity instruments
HSBC Holdings
Retained earnings
HSBC Holdings
Available- for-sale fair value reserve
HSBC Holdings
Other paid-in capital
[9]
HSBC Holdings
Merger reserve
Equity beginning of period at Dec. 31, 2014 $ 199,978 $ 21,527 $ 11,532 $ 137,144 [3],[4],[5] $ 2,143 $ 58 $ (9,265) $ 27,308 $ 190,447 $ 9,531 $ 105,445 $ 9,609 $ 11,918 $ 11,476 $ 34,986 [8] $ 240 $ 2,089 $ 35,127
– profit for the year 15,096     13,522 [3],[4],[5]         13,522 1,574 4,853       4,853 [8]      
Other comprehensive income (13,949)     73 [3],[4],[5] (2,332) (24) (10,779)   (13,062) (887) (57)         (57)    
– available-for-sale investments (3,072)       (2,332)       (2,332) (740) (57)         (57)    
– cash flow hedges (24)         (24)     (24) 0                
– changes in fair value of financial liabilities designated at fair value due to movement in own credit risk 0                   0              
– remeasurement of defined benefit asset/liability 101     82 [3],[4],[5]         82 19                
– share of other comprehensive income of associates and joint ventures (9)     (9) [3],[4],[5]         (9) 0                
– foreign exchange reclassified to income statement on disposal of a foreign operation 0                                  
– exchange differences (10,945)           (10,779)   (10,779) (166)                
Total comprehensive income 1,147     13,595 [3],[4],[5] (2,332) (24) (10,779)   460 687 4,796       4,853 [8] (57)    
Shares issued under employee remuneration and share plans 147 736   (589) [3],[4],[5]         147   677 45 691   (59) [8]      
Shares issued in lieu of dividends and amounts arising thereon 3,162     3,162 [3],[4],[5]         3,162   3,162 188 (188)   3,162 [8]      
Capital securities issued 3,580   3,580           3,580   3,544     3,544        
Dividends to shareholders (11,357)     (10,660) [3],[4],[5]         (10,660) (697) (10,660)       (10,660) [8]      
Cost of share-based payment arrangements 757     757 [3],[4],[5]         757   86       86 [8]      
Other movements 104     567 [3],[4],[5]         567 (463) 364       (144) [8]   508  
Equity end of period at Dec. 31, 2015 197,518 22,263 15,112 143,976 [3],[4],[5] (189) 34 (20,044) 27,308 188,460 9,058 107,414 9,842 12,421 15,020 32,224 [8] 183 2,597 35,127
– profit for the year 3,446     2,479 [3],[4],[5]         2,479 967 6,595       6,595 [8]      
Other comprehensive income (8,398)     59 [3],[4],[5] (271) (61) (7,994)   (8,267) (131) (968)       (896) (72)    
– available-for-sale investments (299)       (271)       (271) (28) (72)         (72)    
– cash flow hedges (68)         (61)     (61) (7)                
– changes in fair value of financial liabilities designated at fair value due to movement in own credit risk 0                   (896)       (896) [8]      
– remeasurement of defined benefit asset/liability 7     5 [3],[4],[5]         5 2                
– share of other comprehensive income of associates and joint ventures 54     54 [3],[4],[5]         54                  
– foreign exchange reclassified to income statement on disposal of a foreign operation 1,894           1,894   1,894                  
– exchange differences (9,986)           (9,888)   (9,888) (98)                
Total comprehensive income (4,952)     2,538 [3],[4],[5] (271) (61) (7,994)   (5,788) 836 5,627       5,699 [8] (72)    
Shares issued under employee remuneration and share plans 27 452   (425) [3],[4],[5]         27   401 35 417   (51) [8]      
Shares issued in lieu of dividends and amounts arising thereon 3,040     3,040 [3],[4],[5]         3,040   3,040 219 (219)   3,040 [8]      
Net increase in treasury shares (2,510)     (2,510) [3],[4],[5]         (2,510)   (2,510)       (2,510) [8]      
Capital securities issued 1,998   1,998           1,998   1,984     1,984        
Dividends to shareholders (12,198)     (11,279) [3],[4],[5]         (11,279) (919) (11,279)       (11,279) [8]      
Cost of share-based payment arrangements 534     534 [3],[4],[5]         534   34       34 [8]      
Other movements (879)     921 [3],[4],[5] (17)       904 (1,783) 147       499 [8] 1 (353)  
Equity end of period at Dec. 31, 2016 182,578 22,715 17,110 136,795 [3],[4],[5] (477) (27) (28,038) 27,308 175,386 7,192 104,858 10,096 12,619 17,004 27,656 [8] 112 2,244 35,127
– profit for the year 11,879     10,798 [3],[4],[5]         10,798 1,081 5,539       5,539 [8]      
Other comprehensive income 9,383     328 [3],[4],[5] 131 (194) 8,966   9,231 152 (881)       (828) [8] (53)    
– available-for-sale investments 146       131       131 15 (53)         (53)    
– cash flow hedges (192)         (194)     (194) 2                
– changes in fair value of financial liabilities designated at fair value due to movement in own credit risk (2,024)     (2,024)         (2,024)   (828)       (828) [8]      
– remeasurement of defined benefit asset/liability [10] 2,419     2,395 [3],[4],[5]         2,395 24                
– share of other comprehensive income of associates and joint ventures (43)     (43) [3],[4],[5]         (43)                  
– foreign exchange reclassified to income statement on disposal of a foreign operation 0                                  
– exchange differences 9,077           8,966   8,966 111                
Total comprehensive income 21,262     11,126 [3],[4],[5] 131 (194) 8,966   20,029 1,233 4,658       4,711 [8] (53)    
Shares issued under employee remuneration and share plans 56 622   (566) [3],[4],[5]         56   570 38 584   (52) [8]      
Shares issued in lieu of dividends and amounts arising thereon 3,206     3,206 [3],[4],[5]         3,206   3,205 190 (190)   3,205 [8]      
Capital securities issued 5,140   5,140           5,140   5,103     5,103        
Dividends to shareholders (12,211)     (11,551) [3],[4],[5]         (11,551) (660) (11,551)       (11,551) [8]      
Cost of share-based payment arrangements 500     500 [3],[4],[5]         500   (2)       (2) [8]      
Cancellation of shares (3,000) (3,000)             (3,000)   (3,000) (164) (2,836)          
Other movements 340     489 [3],[4],[5] (4) (1)     484 (144) (54)       (64) [8] 0 10  
Equity end of period at Dec. 31, 2017 $ 197,871 $ 20,337 $ 22,250 $ 139,999 [3],[4],[5] $ (350) $ (222) $ (19,072) $ 27,308 $ 190,250 $ 7,621 $ 103,787 $ 10,160 $ 10,177 $ 22,107 $ 23,903 [8] $ 59 $ 2,254 $ 35,127
[1] For further details refer to Note 31. In February 2017, HSBC announced a share buy-back of up to $1.0bn. Subsequently, HSBC completed a $1.0bn share buy-back in April 2017. In July 2017, HSBC announced a further share buy-back of up to $2.0bn. Subsequently, HSBC completed a $2.0bn share buy-back in November 2017.
[2] During 2017, HSBC Holdings issued $3,000m, SGD1,000m and €1,250m of perpetual subordinated contingent convertible capital securities, on which there were $14m of external issuance costs, $37m of intra-group issuance costs and $10m of tax benefits. In 2016, HSBC Holdings issued $2,000m of perpetual subordinated contingent convertible capital securities, after issuance costs of $6m and tax benefits of $4m. In 2015, HSBC Holdings issued $2,450m and €1,000m of perpetual subordinated contingent convertible capital securities, on which there were $12m of external issuance costs, $25m of intra-group issuance costs and $19m of tax. Under IFRSs these issuance costs and tax benefits are classified as equity.
[3] At 1 January 2017, the cumulative changes in fair value attributable to changes in own credit risk of financial liabilities designated at fair value was a loss of $1,672m.
[4] At 31 December 2017, retained earnings included 360,590,019 treasury shares (2016: 353,356,251; 2015: 81,580,180). In addition, treasury shares are also held within HSBC’s Insurance business retirement funds for the benefit of policyholders or beneficiaries within employee trusts for the settlement of shares expected to be delivered under employee share schemes or bonus plans, and the market-making activities in Markets.
[5] Cumulative goodwill amounting to $5,138m has been charged against reserves in respect of acquisitions of subsidiaries prior to 1 January 1998, including $3,469m charged against the merger reserve arising on the acquisition of HSBC Bank plc. The balance of $1,669m has been charged against retained earnings.
[6] At 31 December 2015, our operations in Brazil were classified as held for sale. The cumulative amount of other reserves attributable to these operations were as follows: available-for-sale fair value reserve debit of $176m, cash flow hedging reserve credit of $34m and foreign exchange reserve debit of $2.6bn.
[7] Statutory share premium relief under Section 131 of the Companies Act 1985 (the ‘Act’) was taken in respect of the acquisition of HSBC Bank plc in 1992, HSBC France in 2000 and HSBC Finance Corporation in 2003, and the shares issued were recorded at their nominal value only. In HSBC’s consolidated financial statements the fair value differences of $8,290m in respect of HSBC France and $12,768m in respect of HSBC Finance Corporation were recognised in the merger reserve. The merger reserve created on the acquisition of HSBC Finance Corporation subsequently became attached to HSBC Overseas Holdings (UK) Limited (‘HOHU’), following a number of intra-group reorganisations. During 2009, pursuant to Section 131 of the Companies Act 1985, statutory share premium relief was taken in respect of the rights issue and $15,796m was recognised in the merger reserve. The merger reserve includes a deduction of $614m in respect of costs relating to the rights issue, of which $149m was subsequently transferred to the income statement. Of this $149m, $121m was a loss arising from accounting for the agreement with the underwriters as a contingent forward contract. The merger reserve excludes the loss of $344m on a forward foreign exchange contract associated with hedging the proceeds of the rights issue.
[8] At 31 December 2017, retained earnings included 326,843,840 ($2,542m) of treasury shares (2016: 325,499,152 ($2,499m); 2015: 67,881 ($1m)). The increase principally reflects the share buy-back initiative, with the purchase of 328.2m ordinary shares ($3,000m) all of which were cancelled during the year and used to reduce outstanding ordinary shares. In addition, treasury shares are held to fund employee share plans.
[9] Other paid-in capital arises from the exercise and lapse of share options granted to employees of HSBC Holdings subsidiaries.
[10] An actuarial gain of $1,730m has arisen as a result of the remeasurement of the defined benefit pension obligation of the HSBC Bank (UK) Pension Scheme. Refer to Note 5 for further detail.